Ultrasound‐guided high‐intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study

S Luo, Sheng‐Dean Luo, Cai Zhang, C Zhang, J P Huang, JP Huang, G-H Huang, G H Huang, J He, Jia He
BJOG: An International Journal of Obstetrics & Gynaecology · 2017 · vol. 124(S3) , pp. 59–63 · doi:10.1111/1471-0528.14741 · PMID:28856852 · W2750699795
article OA: bronze CC0 ⤵ 28 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Ultrasound-guided high-intensity focused ultrasound effectively ablated abdominal wall endometriosis lesions, significantly reducing lesion volume and pain scores with only temporary local edema and no severe complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To evaluate the safety and efficacy of ultrasound‐guided high‐intensity focused ultrasound ( US g HIFU ) for treating abdominal wall endometrioses ( AWE ). Design A retrospective study. Setting Department of Obstetrics and Gynaecology in China. Population Patients with abdominal wall endometriosis. Methods From August 2010 to April 2014, 32 patients with AWE were treated with US g HIFU in our hospital. US g HIFU treatment was performed with the Model JC ‐200 High Intensity Focused Ultrasound Tumor Therapeutic System. The symptom relief and the adverse effects were evaluated after US g HIFU ablation. Main outcome measures US g HIFU as a new treatment option for patients with AWE . Results Contrast‐enhanced ultrasound showed that all lesions were successfully ablated with US g HIFU . The follow‐up results showed that the average volume of AWE lesions at 6 months after US g HIFU was significantly smaller than that before treatment (2.80 ± 0.12 versus 1.33 ± 0.31 cm 3 ). The pain scores at 6 months after treatment were significantly lower than those before treatment (6.80 ± 2.64 versus 1.80 ± 0.3). The non‐perfused volume (indicative of successful ablation) was measured in all patients immediately after treatment, ranging from 0.9 to 2.1 cm 3 (median: 1.6 cm 3 ), and the fractional ablation ranged from 87% to 100% (median: 94%). Local oedema was observed in these patients, lasting for 1–3 days only. No severe complications occurred during the follow‐up period. Conclusions Based on our study, US g HIFU ablation is a safe and effective method for treating AWE . Tweetable abstract As a non‐invasive treatment technique, HIFU could be used to treat abdominal wall endometriosis.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Abdominal Wall Endometriosis High-Intensity Focused Ultrasound Ablation Muscular Diseases Abdominal Wall Adult Endometriosis Female High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Muscular Diseases Operative Time Postoperative Complications Postoperative Complications Retrospective Studies Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (28)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:19.560968+00:00
License: CC0 · commercial use OK